SAMSCA: payments to doctors
Payments that named SAMSCA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $710K
- Providers
- 3,061
- Transactions
- 6,962
- Average per transaction
- $102
The per-transaction average — $102 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,061 providers the average total is $232, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $324,895 | 45.7% |
| Otsuka America Pharmaceutical, Inc. | $306,369 | 43.1% |
| Otsuka Pharmaceutical Co., Ltd. | $78,932 | 11.1% |